Ramirez B and Richter JE |
Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. |
1993 |
Aliment. Pharmacol. Ther. |
pmid:8094981
|
Haans JJ and Masclee AA |
Review article: The diagnosis and management of gastroparesis. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:18081647
|
McCallum RW and Cynshi O |
Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:17894654
|
Chen CL et al. |
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11929393
|
Winstead NS and Wilcox CM |
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:17848180
|
Brand RM et al. |
Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9218087
|
Annese V et al. |
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9218089
|
van Erpecum KJ et al. |
Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10903008
|
Chiba T et al. |
Motilides accelerate regional gastrointestinal transit in the dog. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886053
|
Landry C et al. |
Could oral erythromycin optimize high energy continuous enteral nutrition? |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971296
|
Ehrenpreis ED et al. |
Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9690728
|
Jameson JS et al. |
Oral or intravenous erythromycin has no effect on human distal colonic motility. |
1992 |
Aliment. Pharmacol. Ther. |
pmid:1420750
|
Osato MS et al. |
Comparative efficacy of new investigational agents against Helicobacter pylori. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284777
|
Medhus AW et al. |
Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651665
|
Curry JI et al. |
Review article: erythromycin as a prokinetic agent in infants and children. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11328252
|
Kendall BJ et al. |
The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9146779
|
Boecxstaens V et al. |
Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21517922
|
Laine L et al. |
Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791949
|
Wehrmann T et al. |
Effect of erythromycin on human biliary motility. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791972
|
Mosonyi L et al. |
[Infectious and neoplastic complications in rheumatoid arthritis]. |
1974-1975 |
Allerg Immunol (Leipz) |
pmid:4282826
|